- Conditions: Bradycardia; Desaturation
Interventions: Drug: Provision of atropine; Drug: Placebo
Sponsors: University of Manitoba; University of Manitoba
Recruiting - verified May 2012 - Condition: Obesity
Intervention: Drug: Propofol, Fentanyl
Sponsors: Stanford University; Stanford University; National Institute of General Medical Sciences (NIGMS)
Recruiting - verified May 2012 - Condition: Pain
Interventions: Drug: fentanyl; Drug: fentanyl, sufentanil
Sponsors: Pacira Pharmaceuticals, Inc; Pacira Pharmaceuticals, Inc
Recruiting - verified April 2012 - Condition: Stillborn Caesarean Section
Interventions: Drug: Bupivacaine plain; Drug: Ropivacaine plain; Drug: Levobupivacaine plain; Drug: bupivacaine plain +fentanyl; Drug: ropivacaine plain +. fentanyl; Drug: Levobupivacaine plain +fentanyl
Sponsors: University of Patras; University of Patras
Recruiting - verified April 2012 - Conditions: Post-operative Nausea; Post-operative Vomiting; Post-discharge Nausea; Post-discharge Vomiting
Intervention: Other: Anesthesia and postoperative medication and fluid protocol
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Institute of Dental and Craniofacial Research (NIDCR)
Not yet recruiting - verified May 2012 - Conditions: Valve Heart Disease; Elective Cesarean Delivery
Interventions: Drug: Placebo; Drug: Ketorolac-Lidocaine
Sponsors: Mansoura University; Mansoura University
Recruiting - verified April 2012 - Condition: Pain
Interventions: Drug: bupivacaine, fentanyl; Drug: fentanyl
Sponsors: Samuel Lunenfeld Research Institute, Mount Sinai Hospital; Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Recruiting - verified March 2012 - Condition: IOP Changes Due to Anesthesia (Healthy Patients)
Intervention: Drug: Sevoflurane
Sponsors: Tel-Aviv Sourasky Medical Center; Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified April 2012 - Condition: Stillborn Caesarean Section
Interventions: Drug: Bupivacaine- Fentanyl - Normal Saline; Drug: Ropivacaine-Fentanyl-Normal Saline; Drug: Levobupivacaine- Fentanyl- Normal Saline; Drug: Bupivacaine + Fentanyl; Drug: Ropivacaine + Fentanyl; Drug: Levobupivacaine + Fentanyl
Sponsors: University of Patras; University of Patras
Recruiting - verified April 2012 - Condition: General Anesthesia
Intervention: Drug: propofol
Sponsors: Ethicon Endo-Surgery; Ethicon Endo-Surgery
Recruiting - verified March 2012 - Condition: Lower Urinary Tract Obstructive Syndrome
Interventions: Procedure: CYSTO; Procedure: Vesico-amniotic shunt
Sponsors: University of Sao Paulo General Hospital; Nanci Valeis
Not yet recruiting - verified March 2012 - Conditions: Pain; Opioid Tolerance; Analgesia Tolerance
Interventions: Drug: Dextromethorphan; Drug: Placebo
Sponsors: King Abdullah International Medical Research Center; King Abdullah International Medical Research Center
Recruiting - verified March 2012 - Conditions: Pain, Postoperative; Chronic Pain
Interventions: Drug: Methadone; Drug: Fentanyl
Sponsors: NorthShore University HealthSystem Research Institute; NorthShore University HealthSystem Research Institute
Recruiting - verified February 2012 - Condition: Prostate Cancer
Interventions: Drug: epidural 250mL of 0.2% ropivacaine and 2 μg/mL of fentanyl, 5 mL/hr continuous infusion and 0.5 mL bolus dose; Drug: no epidural drug administered
Sponsors: Yonsei University; Yonsei University
Recruiting - verified March 2012 - Condition: Postoperative Pain.
Interventions: Drug: Subpleural pain catheter with infusion of 0.125% bupivacaine; Drug: Standard acute pain management
Sponsors: Inova Health Care Services; Inova Health Care Services
Not yet recruiting - verified February 2012 - Conditions: Abscess; Pain
Interventions: Drug: Intranasal Fentanyl; Drug: Intravenous Morphine
Sponsors: Columbia University; Columbia University
Recruiting - verified March 2012 - Conditions: Nausea; Vomiting
Intervention: Drug: Fentanyl
Sponsors: Yonsei University; Yonsei University
Recruiting - verified February 2012 - Conditions: Ultrasound; CT Scans; MRIs
Interventions: Drug: Dexmedetomidine; Drug: Midazolam; Drug: Fentanyl
Sponsors: Hospira, Inc.; Hospira, Inc.
Recruiting - verified April 2012 - Condition: Malignant Neoplasm
Interventions: Drug: placebo administration; Drug: EMLA; Drug: propofol; Drug: fentanyl citrate
Sponsors: Comprehensive Cancer Center of Wake Forest University; Comprehensive Cancer Center of Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Conditions: Advanced Cancers; Dyspnea
Interventions: Drug: Fentanyl; Other: Placebo; Other: Walking Tests; Behavioral: Questionnaires
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified April 2012 - Condition: Endoscopy
Interventions: Drug: Midazolam; Drug: Fentanyl; Other: Placebo
Sponsors: St. Joseph's Healthcare Hamilton; St. Joseph's Healthcare Hamilton; McMaster University
Not yet recruiting - verified February 2012 - Condition: Anesthesia
Interventions: Drug: Midazolam; Drug: Fentanyl; Drug: Morphine
Sponsors: Hospira, Inc.; Hospira, Inc.
Recruiting - verified April 2012 - Randomized Controlled Trial Comparing Postoperative Pain Following TAH With GA vs. Combined GA + SABCondition: Hysterectomy
Interventions: Drug: General Anesthesia + Spinal anesthesia combined; Drug: General Anesthesia (control group)
Sponsors: University of Saskatchewan; University of Saskatchewan
Not yet recruiting - verified January 2012 - Condition: Emergence Agitation
Interventions: Drug: Administration of propofol; Drug: Administration of fentanyl; Drug: Administration of saline
Sponsors: Yonsei University; Yonsei University
Recruiting - verified January 2012 - Conditions: Neonatal Neurobehavior; Breastfeeding Outcomes
Interventions: Drug: Bolus 10mL 0.25% bupivacaine/ep 1:600,000; infusion 10mL/hour 0.25% bupivacaine and epi 1:800,000; Drug: Bolus 10mL 0.25% bupivacaine/ epinephrine 1:600,000;infusion 10mL/hour 0.25% bupivacaine, 2 mcg/mL fentanyl, and epinephrine 1:800,000; Drug: Bolus 10mL 0.25% bupivacaine, 10mcg/mL fentanyl, and epi 1:600,000; infusion 10mL/hour 0.25% bupivacaine, 2.5 mcg/mL fentanyl, and epi 1:800,000; Drug: Bolus 10mL 0.25% bupivacaine, 5 mcg/mL fentanyl, and epi 1:600,000; infusion 10mL/hour 0.25% bupivacaine, 3.5 mcg/mL fentanyl, and epi 1:800,000; Drug: No epidural fentanyl or bupivacaine
Sponsors: University Hospital Case Medical Center; University Hospital Case Medical Center
Not yet recruiting - verified April 2012 - Condition: Cleft Palate
Interventions: Drug: Oral acetaminophen; Drug: Ofirmev®; Drug: Opioid only
Sponsors: Loma Linda University; Loma Linda University
Recruiting - verified December 2011 - Conditions: Tethered Spinal Cord; Brain Tumor; Cranio Cervical Compression
Intervention: Other: Isoflurane, Propofol, Dexmedetomidine
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Recruiting - verified January 2012 - Conditions: Maternal Anaesthesia and Analgesia Affecting Fetus or Newborn; Breast Feeding; Fentanyl; Bupivacaine; Nalbuphine
Intervention:
Sponsors: University Hospital Case Medical Center; University Hospital Case Medical Center
Recruiting - verified February 2012 - Conditions: Coronary Artery Disease; Valvular Heart Disease
Interventions: Drug: etomidate; Drug: thiopentone
Sponsors: Mahidol University; Mahidol University
Recruiting - verified December 2011 - Conditions: Colon Cancer; Rectal Cancer; Colonic Diverticulosis
Interventions: Drug: Fentanyl; Drug: Propofol; Drug: Midazolam
Sponsors: Saint Joseph Mercy Health System; Saint Joseph Mercy Health System
Recruiting - verified December 2011 - Conditions: Postoperative Pain; Quality of Recovery; Satisfaction
Intervention: Other: PVB
Sponsors: Sun Yat-sen University; Nai Liang Li
Not yet recruiting - verified December 2011 - Conditions: Anemia, Sickle Cell; Pain
Interventions: Drug: Fentanyl Citrate; Drug: Normal Saline
Sponsors: Montefiore Medical Center; hnin khine
Recruiting - verified April 2012 - Condition: Anesthesia
Intervention:
Sponsors: Xijing Hospital; Xijing Hospital
Recruiting - verified May 2012 - Condition: Pain
Interventions: Drug: 150% Oral Morphine Equivalent (OME); Other: Clinical Judgment
Sponsors: Abbott Northwestern Hospital; Abbott Northwestern Hospital; Allina Hospitals and Clinics
Recruiting - verified October 2011 - Condition: Anaesthesia
Intervention: Other: Sedation depth
Sponsors: Melbourne Health; Melbourne Health
Recruiting - verified October 2011 - Conditions: Break Through Pain; Cancer
Intervention: Drug: Intranasal Fentanyl Spray (INFS)
Sponsors: Nycomed; Nycomed
Recruiting - verified May 2012 - Conditions: Newborn; Preterm; Intubation
Interventions: Drug: Atropine, Fentanyl, Mivacurium; Drug: Atropine, Fentanyl, Mivacurium
Sponsors: University of Ulm; University of Ulm
Recruiting - verified September 2011 - Conditions: Mediastinal Lymphadenopathies; Mediastinal Masses; Hilar Lymphadenopathies
Intervention:
Sponsors: Baylor College of Medicine; Baylor College of Medicine
Recruiting - verified October 2011 - Condition: Children Under General Anesthesia
Intervention: Procedure: endotracheal intubation
Sponsors: Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile
Recruiting - verified August 2009 - Condition: Chronic Pain
Intervention: Drug: use of fentanyl patch that was halved
Sponsors: Meir Medical Center; Meir Medical Center
Not yet recruiting - verified July 2011 - Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Ketamine; Drug: Saline
Sponsors: Yonsei University; Yonsei University
Recruiting - verified February 2012 - Condition: Coronary Artery Bypass Surgery
Interventions: Drug: Ketamine; Drug: Etomidate
Sponsors: Baskent University; Baskent University
Recruiting - verified June 2011 - Condition: Opioid Use During Medical Care
Intervention:
Sponsors: Albany Medical College; Albany Medical College
Recruiting - verified June 2011 - Condition: Pain
Interventions: Drug: Preservative free morphine; Drug: Fentanyl
Sponsors: Goodman, Evan, M.D.; Goodman, Evan, M.D.
Recruiting - verified May 2011 - Condition: Opioid Dependence
Intervention: Drug: Fentanyl
Sponsors: University of Adelaide; University of Adelaide
Not yet recruiting - verified May 2011 - Condition: Postoperative Pain
Interventions: Drug: Pregabalin; Drug: Pregabalin
Sponsors: Tel-Aviv Sourasky Medical Center; Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified June 2011 - Condition: Pain
Interventions: Drug: Fentanyl; Drug: Fentanyl
Sponsors: Johns Hopkins University; Johns Hopkins University
Recruiting - verified April 2012 - Conditions: Premature Birth of Newborn; Critically Ill
Interventions: Drug: Methadone; Drug: Methadone
Sponsors: Children's Research Institute; Children's Research Institute
Recruiting - verified April 2012 - Condition: Pain
Intervention: Drug: SL fentanyl
Sponsors: Orexo AB; Orexo AB
Recruiting - verified March 2011 - Condition: Chronic Pain
Interventions: Drug: Remifentanil; Drug: Fentanyl; Drug: Normal saline
Sponsors: University of Athens; University of Athens
Recruiting - verified March 2012 - Condition: Pain
Interventions: Drug: Fentanyl; Drug: Fentanyl; Drug: Oxycodone/acetaminophen; Drug: oxycodone/acetaminophen
Sponsors: University of Oklahoma; Stephen Thomas; University of Oklahoma
Recruiting - verified February 2012 - Conditions: Intubation; General Anesthesia
Interventions: Procedure: Tracheal intubation through LMA-Fastrach®; Procedure: Tracheal intubation through I-gel®
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting - verified April 2012 - Condition: Pain
Intervention: Procedure: Spinal anesthesia with Fentanyl+ Morphine
Sponsors: Rambam Health Care Campus; Rambam Health Care Campus
Recruiting - verified November 2010 - Conditions: Persistent Pain; Postoperative Hyperalgesia
Intervention: Drug: Ketamine
Sponsors: Hospital Clinic of Barcelona; Hospital Clinic of Barcelona
Recruiting - verified June 2011 - Conditions: Child Comfort; Morphine; Intensive Care Units; Pediatric
Interventions: Drug: Alfentanil; Drug: Sufentanil
Sponsors: University Hospital, Grenoble; University Hospital, Grenoble
Recruiting - verified January 2012 - Conditions: Pro-inflammatory Activity; Immunologic Activity Alteration [PE]
Interventions: Drug: Fentanyl; Other: Cold pressor test; Other: Fentanyl plus cold pressor test
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified February 2012 - Conditions: Pain, Postoperative; Breast Cancer; Postoperative Nausea and Vomiting
Interventions: Drug: fentanyl; Drug: beta-blocker (esmolol, metropolol)
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke
Recruiting - verified February 2012 - Condition: Lung Cancer
Interventions: Other: General-epidural anesthesia and analgesia; Other: Balanced general anesthesia and postoperative opioids
Sponsors: Outcomes Research Consortium; Outcomes Research Consortium
Recruiting - verified August 2011 - Condition: Acute Traumatic Pain in Aeromedical Patients
Interventions: Drug: Ketamine; Drug: Fentanyl
Sponsors: University of Utah; University of Utah
Not yet recruiting - verified July 2011 - Conditions: Pain; Breastfeeding
Intervention:
Sponsors: Northwestern University; Northwestern University
Recruiting - verified January 2012 - Condition: Chronic Pain
Interventions: Drug: Morphine; Drug: Oxycodone; Drug: Fentanyl; Drug: Buprenorphine
Sponsors: IRCCS Policlinico S. Matteo; IRCCS Policlinico S. Matteo; University of Pavia
Recruiting - verified February 2012 - Conditions: Labor; Pain
Interventions: Drug: Bupivacaine epidural; Drug: Remifentanil
Sponsors: Hadassah Medical Organization; Hadassah Medical Organization
Recruiting - verified February 2010 - Condition: Colon Cancer
Interventions: Procedure: Regional anesthesia and analgesia; Drug: general anesthesia followed by opioid analgesia
Sponsors: Outcomes Research Consortium; Outcomes Research Consortium
Recruiting - verified May 2012 - Conditions: Peripheral Vascular Diseases; Arterial Occlusive Diseases; Leg Ulcer; Gangrene; Ischemia
Interventions: Procedure: Bone marrow punction; Procedure: BM-MNC infusion; Procedure: Placebo infusion
Sponsors: UMC Utrecht; UMC Utrecht; Catharijne Stichting
Recruiting - verified November 2011 - Conditions: Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Pain; Perioperative/Postoperative Complications; Sarcoma
Interventions: Drug: fentanyl citrate; Drug: hydromorphone hydrochloride; Drug: ropivacaine hydrochloride
Sponsors: National Cancer Institute (NCI); University of California, San Francisco; National Cancer Institute (NCI)
Recruiting - verified September 2007


